Recurrence of a Chondroid Tenosynovial Giant Cell Tumor in the Temporomandibular Joint (P9-6.013)

To describe radiologic, pathologic, and clinical findings associated with a chondroid tenosynovial giant cell tumor (CTGCT), harboring a fibronectin 1 (FN1) tyrosine endothelial kinase (TEK) gene fusion that recurred within 1 year of initial resection.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000208461
Primary Topic
Musculoskeletal synovial abnormalities and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recurrence of a Chondroid Tenosynovial Giant Cell Tumor in the Temporomandibular Joint (P9-6.013)

Ali Khawaja, Uğur Sener, Derek Richard Johnson, Andrew Folpe et al.
Neurology
Musculoskeletal synovial abnormalities and treatments
article

Recurrence of a Chondroid Tenosynovial Giant Cell Tumor in the Temporomandibular Joint (P9-6.013)

Ali Khawaja, Uğur Sener, Derek Richard Johnson, Andrew Folpe, Guiseppe Lanzino, Jorge Torres‐Mora
article en

Abstract

To describe radiologic, pathologic, and clinical findings associated with a chondroid tenosynovial giant cell tumor (CTGCT), harboring a fibronectin 1 (FN1) tyrosine endothelial kinase (TEK) gene fusion that recurred within 1 year of initial resection.

NeurologyVol. 104(7_Supplement_1)
Centennial Medical Center (US), Mayo Clinic in Arizona (US)
Openalex Percentile: Top 89%
Musculoskeletal synovial abnormalities and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.